SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+6.86%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$198M
AUM Growth
+$198M
(-1.4%)
Cap. Flow
-$11.4M
Cap. Flow
% of AUM
-5.75%
Top 10 Holdings %
Top 10 Hldgs %
37.09%
Holding
72
New
13
Increased
19
Reduced
13
Closed
21
Top Buys
| 1 |
Molina Healthcare
MOH
|
$4.67M |
| 2 |
Humana
HUM
|
$4.14M |
| 3 |
Eli Lilly
LLY
|
$4.01M |
| 4 |
Integra LifeSciences
IART
|
$3.72M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$3.68M |
Top Sells
| 1 |
Universal Health Services
UHS
|
$6.04M |
| 2 |
Stryker
SYK
|
$5.99M |
| 3 |
HCA Healthcare
HCA
|
$5.46M |
| 4 |
Tenet Healthcare
THC
|
$4.84M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
$4.17M |
Sector Composition
| 1 | Healthcare | 91.46% |
| 2 | Financials | 2.33% |
| 3 | Energy | 0.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Eli Lilly
LLY
$657B
| $8.03M | 4.05% | 100,000 +50,000 | +100% | +$4.01M |
|
2
Zimmer Biomet
ZBH
$21B
| $7.8M | 3.93% | 60,000 | – | – |
|
|
3
Humana
HUM
$36.5B
| $7.67M | 3.87% | 43,382 +23,382 | +117% | +$4.14M |
|
|
CELG
4
DELISTED
Celgene Corp
CELG
| $7.58M | 3.82% | 72,500 +17,500 | +32% | +$1.83M |
|
5
Amgen
AMGN
$155B
| $7.51M | 3.78% | 45,000 +10,000 | +29% | +$1.67M |
|
6
Merck
MRK
$210B
| $7.49M | 3.78% | 120,000 +30,000 | +33% | +$1.87M |
|
|
ALXN
7
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $7.35M | 3.71% | 60,000 +30,000 | +100% | +$3.68M |
|
8
Johnson & Johnson
JNJ
$427B
| $7.09M | 3.57% | 60,000 +20,000 | +50% | +$2.36M |
|
9
AstraZeneca
AZN
$248B
| $6.57M | 3.31% | 200,000 +90,000 | +82% | +$2.96M |
|
10
BioMarin Pharmaceuticals
BMRN
$11.2B
| $6.48M | 3.27% | 70,000 +30,000 | +75% | +$2.78M |
|
11
Biogen
BIIB
$19.4B
| $6.26M | 3.16% | 20,000 | – | – |
|
12
Centene
CNC
$14.3B
| $6.03M | 3.04% | 90,000 -1,300 | -1% | -$87K |
|
13
Cigna
CI
$80.3B
| $5.86M | 2.96% | 45,000 +25,000 | +125% | +$3.26M |
|
14
Incyte
INCY
$16.5B
| $5.66M | 2.85% | 60,000 +25,000 | +71% | +$2.36M |
|
15
Regeneron Pharmaceuticals
REGN
$61.5B
| $5.63M | 2.84% | 14,000 +4,000 | +40% | +$1.61M |
|
16
Medtronic
MDT
$119B
| $5.62M | 2.83% | 65,000 +5,000 | +8% | +$432K |
|
17
GSK
GSK
$79.9B
| $5.39M | 2.72% | 125,000 +25,000 | +25% | +$1.08M |
|
|
WCG
18
DELISTED
Wellcare Health Plans, Inc.
WCG
| $5.27M | 2.66% | 45,000 +20,000 | +80% | +$2.34M |
|
19
UnitedHealth
UNH
$281B
| $4.9M | 2.47% | 35,000 +20,000 | +133% | +$2.8M |
|
20
Thermo Fisher Scientific
TMO
$186B
| $4.77M | 2.41% | 30,000 | – | – |
|
21
Boston Scientific
BSX
$156B
| $4.76M | 2.4% | 200,000 -100,000 | -33% | -$2.38M |
|
|
22
Molina Healthcare
MOH
$9.8B
| $4.67M | 2.35% | +80,000 | New | +$4.67M |
|
|
AET
23
DELISTED
Aetna Inc
AET
| $4.62M | 2.33% | 40,000 +10,000 | +33% | +$1.15M |
|
24
Vertex Pharmaceuticals
VRTX
$100B
| $4.36M | 2.2% | 50,000 -15,000 | -23% | -$1.31M |
|
25
Becton Dickinson
BDX
$55.3B
| $4.04M | 2.04% | 22,500 +2,500 | +13% | +$449K |
|